NMPA issued four draft guidelines today on September 28, 2022, soliciting public opinions. Feedbacks need to be submitted by November 14, 2022.

• Draft Guideline on Non-invasive Blood Glucose Monitoring Products
• Draft Guideline on Continuous Glucose Monitoring System
• Draft Guideline on Extracorporeal Membrane Oxygenation (ECMO) Temperature Control Device
• Draft Guideline on Mobile ECG and Atrial Fibrillation Detection Product

For an English copy of any guideline above, please email info@ChinaMedDevice.com. We charge nominal fees for the translation.

If you have similar devices entering China, please leave your comments with us. We will consolidate your opinions and send to NMPA.